SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-104359
Filing Date
2021-08-13
Accepted
2021-08-12 19:05:53
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2125001d1_8k.htm   iXBRL 8-K 25198
2 EXHIBIT 99.1 tm2125001d1_ex99-1.htm EX-99.1 75105
6 GRAPHIC tm2125001d1_ex99-1img001.jpg GRAPHIC 6283
  Complete submission text file 0001104659-21-104359.txt   290382

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA armp-20210812.xsd EX-101.SCH 3200
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE armp-20210812_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE armp-20210812_pre.xml EX-101.PRE 22720
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2125001d1_8k_htm.xml XML 3505
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 211169207
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences